Concepedia

Publication | Open Access

Ipragliflozin ameliorates liver damage in non-alcoholic fatty liver disease

DOIFull Paper Access

47

Citations

32

References

2018

Year

Teruki Miyake, Sakiko Yoshida, Shinya Furukawa, Takenori Sakai, Fujimasa Tada, Hidenori Senba, Shin Yamamoto, Yohei Koizumi, Osamu Yoshida, Masashi Hirooka,
Open Medicine

Abstract

Ipragliflozin may be effective in patients with T2DM complicated by NAFLD.

References

YearCitations

Page 1